CClinicalTrials.gg
CompletedNCT04649424Updated Jul 15, 2021

COVID-19 Nasal Swab Trial

An interventional study of CanSwab in Covid19, sponsored by Orthopaedic Innovation Centre. Completed at 2 sites in Canada. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-07-15.

Sponsored by Orthopaedic Innovation Centre · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
169
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this trial is to compare 2 types of nasonasopharyngeal swabs (a new design to a conventional nylon-flocked nasopharyngeal swab) for effectiveness.

Read the detailed description

Compare the Precision ADM "CanSwab" nasopharyngeal swab to a conventional nylon-flocked nasopharyngeal swab on the basis of:

  1. The amount of SARS-CoV2 virus (COVID-19) collected by swabs, measured in CT (thermal cycles)
  2. Clinical concordance rate
  3. Patient comfort during nasopharyngeal sampling procedure
02

Conditions studied

  • Covid19

Browse trials for

03

In context

COVID-19

7,640 studies on the registry are indexed under COVID-19; 488 are open to participants now.

This study's enrollment of 169 is above the median of 100 across 4,099 interventional studies indexed under COVID-19.

Browse COVID-19 studies →

Lead sponsor

Orthopaedic Innovation Centre is the lead sponsor of 6 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • 18 years and older
  • Ability to provide informed consent
  • COVID-19 positive cohort only: a previous, positive COVID-19 test in the last 5 days and patient remains symptomatic

Exclusion criteria

Exclusion criteria:

  • Malformation of the base of the known skull
  • Active nosebleed before the start of the sample
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
169 participants (actual)

Study arms

  • Experimental
    CanSwab - 1st

    CanSwab will be swabbed first

    Device: CanSwab

  • Experimental
    CanSwab - 2nd

    CanSwab will be swabbed second.

    Device: CanSwab

Interventions

  • DeviceCanSwab

    New nasopharyngeal swab design.

06

What researchers measure

Primary outcomes

  1. Amount of SARS-CoV2 virus (COVID-19) collected

    amount of SARS-CoV2 virus (COVID-19) collected measured in CT (thermal cycles).

    Time frame: Baseline

  2. Clinical concordance rate

    Calculate approximate sensitivity and specificity of the CanSwab to the Flocked swab control.

    Time frame: Baseline

  3. Patient comfort

    Patient description of comfort level between the 2 swabs experience measured by "Worse", "Identical" or "Better"

    Time frame: Baseline

07

Study locations

2 sites
  • St. Boniface General Hospital
    Winnipeg, Manitoba R2H 2A6, Canada
  • Health Sciences Centre
    Winnipeg, Manitoba R3E 0Z3, Canada
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 15, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04649424
Lead sponsor
Orthopaedic Innovation Centre
Responsible party
Sponsor
First posted
Dec 2, 2020
Start date
Dec 22, 2020
Primary completion
Apr 13, 2021
Completion
Apr 13, 2021
Last update
Jul 15, 2021

Study contacts

Anand Kumar, MD
principal investigator · Health Sciences Centre

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion